Capromorelin in Dogs

Capromorelin is a prescription appetite stimulant used in dogs. In the United States, the FDA-approved canine product is Entyce, an oral solution labeled for appetite stimulation in dogs. It is not a complete treatment for the reason a dog is not eating. Instead, it is one tool your vet may use while also looking for problems such as nausea, pain, dental disease, kidney disease, cancer, infection, or digestive upset.

This medication can be very helpful when a dog needs support to start eating again, but it should always be used as part of a broader plan. A dog that will not eat may have a mild issue, or it may have a serious medical problem that needs prompt care. If your dog has gone more than about 24 hours with little or no food, is vomiting, seems weak, or is losing weight, contact your vet. Appetite stimulants can improve intake, but they do not replace diagnosis and monitoring.

Capromorelin is generally well tolerated, and one reason vets use it is that it is specifically approved for dogs rather than borrowed from human medicine. The labeled dose is once daily by mouth, and the FDA approval is for appetite stimulation in dogs. Clinical studies showed improved food intake over a short treatment period, and veterinary references note that the safety data are broad enough that the drug does not carry age, weight, or treatment-duration restrictions on the U.S. label.

For pet parents, the main takeaway is this: capromorelin may help a dog feel hungry, but the best plan still depends on why appetite dropped in the first place. Your vet may recommend conservative monitoring and supportive care, a standard diagnostic workup with medication, or a more advanced plan if your dog has a complex illness or ongoing weight loss.

Capromorelin works by activating the ghrelin receptor. Ghrelin is often called the “hunger hormone” because it helps signal appetite through the brain, especially the hypothalamus. When capromorelin stimulates that receptor, many dogs feel more interested in food and may eat more consistently. It also increases growth hormone signaling, which is part of the drug’s pharmacologic effect.

That mechanism matters because some dogs are not refusing food due to pickiness. They may have true appetite suppression from illness, inflammation, nausea, stress, or recovery from surgery. By increasing hunger signaling, capromorelin can help bridge the gap while your vet addresses the underlying cause. In practice, your vet may pair it with other treatments, such as anti-nausea medication, pain control, fluid support, diet changes, or treatment for the primary disease.

Capromorelin is not the same thing as force-feeding, and it is not a cure for weight loss by itself. If a dog is nauseated, painful, dehydrated, or unable to swallow safely, appetite stimulation alone may not be enough. Dogs with regurgitation, suspected aspiration risk, or severe systemic illness may need a different plan. That is why your vet may recommend diagnostics before or during treatment, especially if appetite loss is persistent.

The FDA approval for dogs is based on oral administration once daily at 3 mg/kg. In a controlled study summarized by the FDA, healthy adult Beagles given capromorelin had increased food consumption and body weight over four days. In field use, the medication is intended to stimulate appetite in dogs with reduced intake, but your vet still needs to decide whether it fits your dog’s overall condition.

The most commonly reported side effects in dogs are digestive signs. In the FDA field study for Entyce, diarrhea and vomiting were the most frequent adverse reactions. Hypersalivation, increased thirst, lethargy or depression, abdominal discomfort, flatulence, nausea, and mild changes in kidney-related lab values were also reported. Veterinary references also list polydipsia and hypersalivation among recognized effects.

Most side effects are mild, but they still matter because dogs receiving capromorelin are often already sick. If your dog starts vomiting repeatedly, develops worsening diarrhea, seems very weak, or still refuses food, contact your vet. A medication side effect can look similar to progression of the underlying illness, so your vet may want to adjust the plan rather than continue the same course.

There is also an important cardiovascular caution. Updated FDA safety labeling notes that Entyce can cause transient decreases in heart rate and blood pressure after dosing, so it should be used with caution in dogs that may have cardiac disease or severe dehydration. The same update also added user-safety instructions, including washing hands after administration because the product may be absorbed through the skin.

See your vet immediately if your dog collapses, has trouble breathing, shows severe weakness, cannot keep water down, or has signs of an allergic reaction such as facial swelling or sudden hives. Those reactions are not typical, but a dog with poor appetite can become unstable quickly, especially if an underlying disease is the real driver of the problem.

The FDA-labeled dose for dogs is 3 mg/kg by mouth once daily. Entyce is supplied as a 30 mg/mL oral solution, so the volume given is based on body weight and should be measured carefully with the dosing syringe provided. Because this is a prescription medication, your vet should confirm the exact dose, show you how to measure it, and tell you how long to continue it for your dog’s situation.

Give capromorelin exactly as prescribed. Do not increase the dose if your dog still seems uninterested in food, and do not double up after a missed dose unless your vet tells you to. If you forget a dose, call your vet for guidance. In many cases, they may tell you to give it when remembered unless it is close to the next scheduled dose, but the safest answer depends on your dog’s health status and other medications.

The original FDA effectiveness work evaluated four days of treatment, and the 2025 FDA labeling update specifically notes that effectiveness has not been evaluated beyond four days in the clinical field study. Even so, Merck Veterinary Manual notes that the U.S. safety data are broad enough that the product label does not place age, weight, or treatment-duration restrictions on dogs. That does not mean every dog should stay on it long term. It means your vet should decide whether short-term or longer use makes sense based on response, diagnosis, and monitoring.

Practical administration matters. Use the bottle and syringe exactly as directed, store it securely out of reach of pets, and wash your hands after giving it. If your dog spits out part of the dose, do not automatically redose. Call your vet and explain how much you think was lost so they can advise you safely.

Published veterinary interaction data for capromorelin in dogs are more limited than for many older medications, so the safest approach is to give your vet a complete medication and supplement list before starting it. That includes prescription drugs, over-the-counter products, probiotics, joint supplements, CBD products, and any recent steroid or NSAID use. A dog with poor appetite is often taking several medications at once, and the overall treatment plan matters more than any one product.

In practice, your vet will think less about a single famous interaction and more about the whole patient. For example, if your dog is vomiting, dehydrated, or has heart disease, your vet may be more cautious because Entyce can cause transient drops in heart rate and blood pressure. If your dog is on medications that already affect hydration, blood pressure, sedation, or stomach comfort, your vet may want closer monitoring.

Capromorelin also should not be used in dogs with known hypersensitivity to the drug. If your dog has diabetes, endocrine disease, significant kidney disease, liver disease, or a history of regurgitation or aspiration risk, tell your vet before starting treatment. Those conditions do not automatically rule it out, but they can change how aggressively your vet wants to use an appetite stimulant versus treating nausea, pain, or the primary disease first.

Because appetite loss is a symptom rather than a diagnosis, the most important “interaction” question is often whether capromorelin could mask a worsening problem. If a dog seems hungrier but is still losing weight, vomiting, or acting painful, your vet may recommend more diagnostics instead of continuing medication alone.